ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Criteria and Practice Patterns for Accepting Living Donors with Prior Covid-19: A National Survey

    A. Jawed1, M. Y. Jan2, N. Barros2, O. Adebiyi2, A. Diez3, J. Fridell2, W. Goggins2, M. Yaqub2, M. A. Mujtaba4, T. Taber2, V. Kumar5, K. Lentine6, A. Sharfuddin2

    1Wayne State University, Detroit, IN, 2Indiana University School of Medicine, Indianapolis, IN, 3The Ohio State University, Columbus, OH, 4UTMB Galveston, Galveston, TX, 5University of Alabama, Birmingham, AL, 6St. Louis University, St. Louis, MO

    *Purpose: A critical question facing transplant programs is if, when and how to safely accept living kidney donors (LKD) who have a history and recovered…
  • 2021 American Transplant Congress

    Predictors of Prolonged Length of Stay in Pediatric Kidney Transplantation: Changes Over the Last Three Decades

    K. Goli, N. T. Galvan, R. T. Cotton, J. A. Goss, C. A. O'Mahony, A. Rana

    Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX

    *Purpose: Hospital length of stay (LOS) following kidney transplantation, particularly prolonged LOS, has not shown much improvement since the early 2000s. This study explores changes…
  • 2021 American Transplant Congress

    Plasma Donor-Derived Cell-Free DNA Levels Risk-Stratify Kidney Allograft Injury with Isolated Transplant Glomerulitis

    L. Bu1, S. Anand2, A. Pai3, J. S. Bromberg4, G. Gupta5, I. Moinuddin5, T. Alhamad6, V. Bowers7, S. Ghosh8, W. Tian8, E. Stites9

    1University of Minnesota, Minneapolis, MN, 2Intermountain Medical Center, Murray, UT, 3University of Texas McGovern Medical School, Houston, TX, 4University of Maryland School of Medicine, Baltimore, MD, 5Virginia Commonwealth University, Richmond, VA, 6Washington University in St. Louis, St. Louis, MO, 7Tampa General Hospital, Tampa, FL, 8CareDx, Brisbane, CA, 9University of Colorado, Aurora, CO

    *Purpose: The Banff lesion Glomerulitis (g) characterizes the degree of microvascular glomerular inflammation. Some studies have demonstrated glomerulitis in the absence of C4d in association…
  • 2021 American Transplant Congress

    Higher Calcineurin Inhibitor Levels Associate with Graft Outcomes in Kidney Recipients with De Novo Donor-specific Antibodies of Either Hla Class I or II

    M. Béland, S. De Serres

    Nephrology, CHU de Québec- Université Laval, Québec, QC, Canada

    *Purpose: The development of de novo anti-HLA donor specific antibodies (dnDSA) is associated with poorer outcomes in kidney transplant recipients. We and other previously reported…
  • 2021 American Transplant Congress

    Cancer Among Kidney Transplant Recipients More Than 20 Years After Transplantation: PTLD Remains the Most Common Cancer Type Even in the Very Long-Term

    T. Schachtner, J. Fuhrmann, T. Mueller

    Nephrology, University Hospital Zurich, Zurich, Switzerland

    *Purpose: Due to an improved patient and kidney allograft survival, cancer is increasingly recognized as the major cause of death after kidney transplantation. Cancer risk…
  • 2021 American Transplant Congress

    Who Can be Matched via Kidney Exchange?

    D. C. McElfresh1, M. Curry2, S. E. Booker3, D. Stewart3, M. Stuart3, R. Leishman4, T. Sandholm5, J. Dickerson2

    1Applied Mathematics, University of Maryland, College Park, MD, 2Computer Science, University of Maryland, College Park, MD, 3United Network for Organ Sharing, Seattle, WA, 4UNOS, Seattle, WA, 5Computer Science, Carnegie Mellon University, Pittsburgh, PA

    *Purpose: Valuable time and resources are spent screening medically-compatible patients and donors for kidney exchange. Exchanges with tens or hundreds of patients can have thousands…
  • 2021 American Transplant Congress

    Chances of Renal Recovery in Liver Only Transplant Recipients Who Were Eligible for Simultaneous Liver-Kidney Transplant

    J. Cui1, A. Spann2, A. Shingina2, H. M. Schaefer3, J. C. Slaughter4, S. Alexopoulos5, M. Izzy2

    1Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, TN, 3Nephrology, Vanderbilt University Medical Center, Nashville, TN, 4Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 5Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Progressive decline in renal function is common among patients with end-stage liver disease. Liver transplant (LT) candidates can often develop severely impaired renal function…
  • 2021 American Transplant Congress

    Implementation of a High-risk Medication Report for Waitlisted Liver Transplant Candidates

    M. M. Eiting1, H. Yeh2, M. Cote1, S. Shao1, A. B. Scherrer2, L. Dageforde2, N. Elias2, C. Rogers Marks1

    1Pharmacy, Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA

    *Purpose: Use of high-risk medications (HRMs) at the time of liver transplant may lead to delays in surgery or peri-operative complications (bleeding, drug-drug interactions (DDI),…
  • 2021 American Transplant Congress

    Improving Liver Transplantation Outcomes for Hepatitis C Associated Hepatocellular Carcinoma in Direct-Acting Antiviral Therapy Era

    K. Okumura, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. C. Wolf, S. Nishida

    Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY

    *Purpose: Direct-acting antiviral (DAA) therapy has transformed the outcomes of liver transplantation(LT) in patients with hepatitis C virus (HCV). The aim of this study was…
  • « Previous Page
  • 1
  • …
  • 137
  • 138
  • 139

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences